Adriana Jade's Posts - Sikcell: People living with Sickle Cell2024-03-28T19:28:12ZAdriana Jadehttps://sikcell.com/profile/AdrianaJadehttps://storage.ning.com/topology/rest/1.0/file/get/1956904184?profile=RESIZE_48X48&width=48&height=48&crop=1%3A1https://sikcell.com/profiles/blog/feed?user=0ljr2dbqudksp&xn_auth=noMy Uncle works with medicines, and helps research treatments and cures....he found this for me...tag:sikcell.com,2009-10-31:2131823:BlogPost:92842009-10-31T19:56:37.000ZAdriana Jadehttps://sikcell.com/profile/AdrianaJade
There are two Trials that they are testing on Sickle Cell patients, look them up on Google for more information about these trials, also you can directly contact the investigators by using the phone number or websit provided.<br />
<br />
Trial 1:A Phase II Pharmacodynamic Investigation of the Efficacy of Vorinostat to Induce Fetal Hemoglobin in Adults With Severe Sickle Cell Disease Who Have Failed Prior Therapy<br />
<br />
Dana-Farber Cancer Institute<br />
Brigham and Women's Hospital<br />
Children's Hospital…
There are two Trials that they are testing on Sickle Cell patients, look them up on Google for more information about these trials, also you can directly contact the investigators by using the phone number or websit provided.<br />
<br />
Trial 1:A Phase II Pharmacodynamic Investigation of the Efficacy of Vorinostat to Induce Fetal Hemoglobin in Adults With Severe Sickle Cell Disease Who Have Failed Prior Therapy<br />
<br />
Dana-Farber Cancer Institute<br />
Brigham and Women's Hospital<br />
Children's Hospital Boston<br />
Merck<br />
Investigators<br />
Principal Investigator: Maureen Okam, MD, MPH Brigham and Women's Hospital<br />
Responsible Party: Brigham and Women's Hospital ( Maureen Okam, MD, MPH )<br />
Study ID Numbers: 09-237<br />
Study First Received: October 20, 2009<br />
Contact: Maureen Okam, MD, MPH 617-732-5048<br />
Contact: Ainsley Ross 617-732-8537<br />
<br />
For more information you can go to <a href="http://clinicaltrials.gov/ct2/show/NCT01000155">http://clinicaltrials.gov/ct2/show/NCT01000155</a><br />
<br />
<br />
<br />
<br />
Trial 2:<br />
<br />
A Randomized, Blinded, Placebo-controlled, Dose Escalation Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of HQK 1001 in Subjects with Sickle Cell Disease<br />
<br />
HemaQuest Pharmaceuticals Inc.<br />
Study Director: Susan Perrine, M.D. HemaQuest Pharmaceuticals<br />
Responsible Party: HemaQuest Pharmaceuticals, Inc. ( Susan Perrine, M.D. )<br />
Study ID Numbers: HQP 2008-004<br />
Study First Received: February 11, 2009<br />
For information about this trial email: info@hemaquest.com.Cure Researchtag:sikcell.com,2009-09-12:2131823:BlogPost:80372009-09-12T04:00:00.000ZAdriana Jadehttps://sikcell.com/profile/AdrianaJade
I was wondering what the latest research is on the treatment for sickle cell anemia. Has there been any discoveries in being closer to a cure? -Adriana
I was wondering what the latest research is on the treatment for sickle cell anemia. Has there been any discoveries in being closer to a cure? -Adriana